The largest database of trusted experimental protocols

Dual luciferase assay protocol

Manufactured by Promega
Sourced in United States, Switzerland

The Dual Luciferase Assay protocol is a laboratory technique used to measure the activity of two different luciferase reporter enzymes within the same sample. It allows for the simultaneous quantification of two distinct gene expression events or pathways. The protocol provides a rapid and sensitive way to evaluate the relative activity of the two luciferase reporters.

Automatically generated - may contain errors

14 protocols using dual luciferase assay protocol

1

Overexpression of miR-998 and miR-29a

Check if the same lab product or an alternative is used in the 5 most similar protocols
HeLa cells were cultured in DMEM+10% FBS, and were transfected with the X-treme Gene HP transfection reagent (Roche) according to the manufacturer's protocol. Cells were harvested 24–48 hours post-transfection. pcDNA3/mir-998 generated by PCR amplification of the mir-998 gene and standard molecular cloning techniques. pcDNA3/hsa-mir-29a was generated by insertion of a GeneString (Invitrogen) with the mir-29a gene sequence in pcDNA3. Insert sequences were verified by sequencing analysis. Sequences are in Table S4. Firefly and Renilla luciferase activity were measured using the Dual Luciferase Assay protocol (Promega).
+ Open protocol
+ Expand
2

Dual-Luciferase Assay for Pomc Promoter

Check if the same lab product or an alternative is used in the 5 most similar protocols
AtT-20 cells were concurrently transfected using Lipofectamine 3000 (Thermo Fisher Scientific) with 2 plasmids—one containing the pRL Renilla luciferase gene under the control of the cytomegalovirus promoter (No. E2261, Promega) and the other containing the firefly luciferase gene under the control of the Pomc promoter (–646 bp to +65 bp) (No. 17553, Addgene). Forty-eight hours after transfection, luciferase activity was measured using the dual-luciferase assay protocol (Promega). Transfection was performed 48 hours before measurement of the promoter activity.
+ Open protocol
+ Expand
3

Analyzing Wnt/β-catenin Signaling

Check if the same lab product or an alternative is used in the 5 most similar protocols
Stable HEK293T cells expressing the TopFlash βcatenin-dependent luciferase reporter and Renilla luciferase (Lui et al. 2011 (link)) were transfected with control or TCF7L2-DN plasmid using polyethylenimine. The medium was replaced with a 1:1 ratio of fresh DMEM/Wnt3a or DMEM/control conditioned medium, and cells were assayed 24 h later using the dual-luciferase assay protocol (Promega) using the Envision multilabel plate reader. All TopFlash assays are an average of three replicates.
+ Open protocol
+ Expand
4

Cyclin D1 Luciferase Reporter Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
MCF7 cells and Hela cells were transfected with the appropriate plasmids for 16 h, and the medium was then changed to phenol red-free medium containing 2% charcoal-stripped fetal bovine serum (vol/vol) followed by further incubation for 24 h. The medium was replaced with complete medium and the culture was incubated for another 24 h. The relative luciferase activity of the CCND1-luc reporter was measured by dual-luciferase assay protocol (Promega, Madison, WI, USA) and expressed as fold changes.
+ Open protocol
+ Expand
5

STAT3 Transcriptional Activity Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
HeLa cells were co-transfected with pSTAT3-TA-luc (Beyotime) and pRL-TK (Promega) as a transfection efficiency control in a 6-well plate. After 12 h, cells were transferred to a 48-well plate with complete medium and cultured for 24 h. Cells were pre-treated with different concentration of compounds (in 0.05% DMSO) for 6 h in low FBS medium, and EGF (100 ng/ml) was subsequently added into the wells for 30 min to stimulate STAT3 expression and the cells were incubated for 30 min. In the IFN-α-induced comparative assay, HeLa cells were co-transfected with p-GAS-TA-luc (Biovector, Beijing, China) and pRL-TK in a 24-well plate for 6 h. Cell were cultured with complete medium for another 18 h. The indicated concentrations of compound 1 and S3I-201 were added to each well for 5 h, followed by the addition of 1000 U/ml IFN-α for 1 h to stimulate STAT3/STAT1 expression. Cell lysates were collected according to the dual luciferase assay protocol (Promega). Sample light output was analyzed using a luminometer and the resulting data were normalized relative to pRL-TK values.
+ Open protocol
+ Expand
6

Transient Promoter Activity Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
GmMYB29 amplified from Glycine max var. Williams 82 was inserted into the BamHI-NotI-digested GFP-removed pAN580 vector to generate the effector vector CaMV 35S::MYB29. The open reading frame (ORF) of luciferase (LUC) was cloned from the pGL3 vector (XbaI-XmaI) (Promega, Madison, WI, USA) and introduced into the GFP-loss pAN580 vector to produce the CaMV 35S::LUC plasmid. The CaMV 35S::LUC plasmid was digested by SacI and NheI to remove CaMV 35S, and then the promoter sequence of IFS2 or CHS8, amplified from Glycine max var. Williams 82, was inserted to form the reporter vectors IFS2pro::LUC and CHS8pro::LUC. A Renilla luciferase reporter was used as an internal control for normalization. The transient promoter activity in protoplasts derived from Arabidopsis suspension cells was analyzed by following the Dual Luciferase Assay protocol (Promega).
+ Open protocol
+ Expand
7

Dual Luciferase Assay for Nuclear Receptors

Check if the same lab product or an alternative is used in the 5 most similar protocols
Dual luciferase reporter gene assays for CAR, PXR and FXR were conducted to analyze the capability of Pi and Te to activate these nuclear receptors in HepG2 cells. The plasmids and assays have been described in detail before [16 (link)]. In brief, HepG2 cells were cultivated in 96-well plates and transiently transfected with plasmids (Supplementary Table S5) using TransIT-LT1 (Mirus Bio LLC, Madison, WI, USA) in a relation of 3:1 (TransIT-LT1 [μL]: amount of plasmids [μg]). For the FXR transactivation assay, the first plasmid is based on a fusion protein of GAL4 with the ligand-binding domain (LBD) of FXR. The second plasmid contains a firefly luciferase reporter gene under control of the GAL4-specific upstream activation sequence (UAS). For the CYP7A1 promoter assay, the luciferase reporter construct is driven by a fragment of the promoter of the human FXR-responsive CYP7A1 gene [14 (link)]. All measurements were performed according to the Dual Luciferase Assay protocol as provided by the manufacturer (Promega, Madison, WI, USA) and detailed elsewhere [19 (link),20 (link)] by using a plate reader (Infinite M200PRO, Tecan, Männedorf, Switzerland).
+ Open protocol
+ Expand
8

Wnt Canonical Activation Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
These assays were carried out according to standard protocols64 (link). Briefly, HEK293T cells were plated at 5 × 104 cells per well 24 h before transfection. The following plasmids were used: Prl-TK (Promega) as transfection control, ∆45β-catenin, Wnt1 and Wnt3A (for different levels of Wnt canonical activation), TOPflash (TCF Reporter Plasmid with wild-type TCF-binding sites, Millipore), and FOPflash (mutant TCF binding site, Millipore) as negative control. Luciferase activity was measured following the Dual Luciferase Assay protocol (Promega) at 24 h post-transfection with a Victor3 Multilabel Reader 1420-015.
+ Open protocol
+ Expand
9

Investigating RNAPII inhibition by α-amanitin

Check if the same lab product or an alternative is used in the 5 most similar protocols
The RNAPII inhibitor, α-amanitin (A2263 Sigma, St Louis, MO, USA) was dissolved in bi-distilled sterile water and filtered by 0.2 mm filter. The experiments were performed by using growing doses of α-amanitin, that is, 1, 2, 3, 5, 10 mg/ml on each point of 2000.000 cells/ml or 2 and 10 mg/ml on each point of 500 000–1000 000 cells/ml. After 16 h, the cells were lysed in 700 ml of Qiazol (Qiagen, Venlo, Netherlands) for the RNA extraction.
Transfection of DNA vectors (200–500 ng/50 000 cells) in HEK293T was performed with Lipofectamine2000 (Invitrogen, Carlsbad, CA, USA) in accordance with the manufacturer’s procedures, whereas transfection of MEC-1, MEC-2, WaC3CD5 and K562 was performed using the Amaxa nucleofector (Lonza, Basel, Switzerland) according to the manufacturer’s protocols (plasmids:3000 ng/1 000 000 cells; small interfering RNA 40 pmol/1 000 000 cells). siPOLR3A (sc-90684), siPOLR3G (sc-43507) and small interfering RNA -A as control (sc-37007) were purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA). The efficiency of transfection was determined by cytofluorometry, messenger RNA expression and\or fluorescence microscopy. After transfection of luciferase reporter vectors (pGL3Ren-187/A and pGL3Ren-187/G), the luciferase assay was conducted according to manufacturer’s dual luciferase assay protocol (Promega).
+ Open protocol
+ Expand
10

RNAPII Inhibition Using α-amanitin

Check if the same lab product or an alternative is used in the 5 most similar protocols
The RNAPII inhibitor, α-amanitin (A2263 Sigma, St Louis, MO, USA) was dissolved in bi-distilled sterile water and filtered by 0.2 μm filter. The experiments were performed by using growing doses of a-amanitin, that is, 1, 2, 3, 5, 10 μg/ml on each point of 2000.000 cells/ml or 2 and 10 μg/ml on each point of 500 000–1000 000 cells/ml. After 16 h, the cells were lysed in 700 μl of Qiazol (Qiagen, Venlo, Netherlands) for the RNA extraction.
Transfection of DNA vectors (200–500 ng/50 000 cells) in HEK293T was performed with Lipofectamine2000 (Invitrogen, Carlsbad, CA, USA) in accordance with the manufacturer's procedures, whereas transfection of MEC-1, MEC-2, WaC3CD5 and K562 was performed using the Amaxa nucleofector (Lonza, Basel, Switzerland) according to the manufacturer's protocols (plasmids:3000 ng/1 000 000 cells; small interfering RNA 40 pmol/1 000 000 cells). siPOLR3A (sc-90684), siPOLR3G (sc-43507) and small interfering RNA -A as control (sc-37007) were purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA). The efficiency of transfection was determined by cytofluorometry, messenger RNA expression and\or fluorescence microscopy. After transfection of luciferase reporter vectors (pGL3Ren-187_A and pGL3Ren-187_G), the luciferase assay was conducted according to manufacturer's dual luciferase assay protocol (Promega).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!